Purshottam T, Srivastava R
Biochemistry Division, Defence Research and Development Establishment, Gwalior, India.
Pharmacology. 1989;38(5):319-26. doi: 10.1159/000138552.
Rats were injected intraperitoneally with phenobarbital (PB) and 3-methylcholanthrene (MC) which are microsomal enzyme inducers, and methyl iodide (MeI), cobalt chloride (CoCl2) and tri-o-cresyl phosphate (TOCP) which are inhibitors of the enzymes glutathione transferase, cytochrome (cyt) P-450 and carboxylesterase, respectively, and then challenged with soman (i.p.) to know its LD50. Pretreatment with PB and MC increased and TOCP decreased, whereas MeI as well as CoCl2 did not alter the LD50 value of soman in rats. The 1/2 LD50 dose of soman did not affect the liver microsomal cyt P-450 level, but significantly lowered carboxylesterase (CaE) and cholinesterase (ChE) activities in liver microsomes and in blood plasma. Induction of plasma CaE was more important than microsomal CaE in PB-mediated protection against soman toxicity. Gel filtration of plasma into four protein fractions for their relative soman binding capacity showed that a high-molecular-weight protein fraction (180,000 daltons on SDS-PAGE) which had no CaE activity could bind soman 6 times more than the low-molecular-weight CaE-containing protein fraction (60,000 daltons on SDS-PAGE).
给大鼠腹腔注射微粒体酶诱导剂苯巴比妥(PB)和3 - 甲基胆蒽(MC),以及分别为谷胱甘肽转移酶、细胞色素(cyt)P - 450和羧酸酯酶抑制剂的甲基碘(MeI)、氯化钴(CoCl2)和磷酸三邻甲苯酯(TOCP),然后腹腔注射梭曼以测定其半数致死量(LD50)。用PB和MC预处理会使梭曼的LD50值升高,而用TOCP预处理则会使其降低,而用MeI和CoCl2预处理则不会改变大鼠体内梭曼的LD50值。梭曼的半数致死量剂量不会影响肝脏微粒体细胞色素P - 450水平,但会显著降低肝脏微粒体和血浆中的羧酸酯酶(CaE)和胆碱酯酶(ChE)活性。在PB介导的对梭曼毒性的保护作用中,血浆CaE的诱导比微粒体CaE更重要。将血浆通过凝胶过滤分成四个蛋白质组分以测定它们对梭曼的相对结合能力,结果显示一个无CaE活性的高分子量蛋白质组分(在SDS - PAGE上为180,000道尔顿)对梭曼的结合能力是含低分子量CaE的蛋白质组分(在SDS - PAGE上为60,000道尔顿)的6倍。